Markus Walter Sieger

Chief Executive Officer at Polpharma SA

Markus Walter Sieger

Markus Walter Sieger

Chief Executive Officer at Polpharma SA

Overview
Career Highlights

Fincoord Finance Coordinators Ltd.
Polpharma SA

RelSci Relationships

162

Number of Boards

13

Birthday

1966

Age

52

Relationships
RelSci Relationships are individuals Markus Walter Sieger likely has professional access to. A relationship does not necessarily indicate a personal connection.

Member, Management Board at Polpharma SA

Relationship likelihood: Strong

Member, Management Board at Polpharma SA

Relationship likelihood: Strong

Member, Management Board at Polpharma SA

Relationship likelihood: Strong

Chairman-Management Board at Polpharma SA

Relationship likelihood: Strong

President-European Business at Mylan, Inc.

Relationship likelihood: Strong

Chief Executive Officer at CTD HOLDINGS INC

Relationship likelihood: Strong

Former President & Chief Executive Officer at Herbapol-Lublin SA

Relationship likelihood: Strong

Secretary at International Trading & Investments Holding SA

Relationship likelihood: Strong

Member, Management Board at Polpharma SA

Relationship likelihood: Strong

Member, Management Board at Polpharma SA

Relationship likelihood: Strong

Paths to Markus Walter Sieger
Potential Connections via
Relationship Science
You
Markus Walter Sieger
Chief Executive Officer at Polpharma SA
Career History
Chief Executive Officer
2016 - Current

Polpharma SA develops and manufactures generic drugs. It offers pharmaceutical solutions for cardiological, gastrological, and neurological diseases. The company has offices in Russia, Lithuania, Ukraine, and Kazakhstan. Polpharma was founded in 1935 and is headquartered in Starogard Gdanski, Poland.

Managing Partner
1994 - Current
Professional
Current
Boards & Committees
Director
2015 - Current

Akrikhin Pharmaceuticals OAO engages in the production of pharmaceutical products. Its portfolio focuses on cardiology, neurology, dermatology, gynecology, and pediatrics. It also manufactures drugs for diabetes and tuberculosis treatment. The company was founded in 1936 and is headquartered in Moscow, Russia.

Lead Independent Director
2014 - Current

CTD Holdings, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The company was founded by C.E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Member, Supervisory Board
Current

Polpharma SA develops and manufactures generic drugs. It offers pharmaceutical solutions for cardiological, gastrological, and neurological diseases. The company has offices in Russia, Lithuania, Ukraine, and Kazakhstan. Polpharma was founded in 1935 and is headquartered in Starogard Gdanski, Poland.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Markus Walter Sieger. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Markus Walter Sieger's profile does not indicate a business or promotional relationship of any kind between RelSci and Markus Walter Sieger.